Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Royal DSM Stories

2014-04-08 08:29:58

DALLAS, April 8, 2014 /PRNewswire/ -- ReportsnReports.com offers Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, Aquaculture, Others) & by Geography (North America, Europe, Asia-Pacific, Rest of the World) - Global Trends & Forecasts to 2019 and Nutraceutical Ingredient Market by Type (Probiotics, Proteins, Plant Extracts, Minerals, Vitamins, Fibers, Carotenoids & Others) by Application...

2014-02-04 16:23:29

PARSIPPANY, N.J., Feb. 4, 2014 /PRNewswire/ -- DSM Nutritional Products, a subsidiary of Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has entered into a collaboration with SyntheZyme LLC under a Development and Option to License Agreement to develop products based on SyntheZyme LLC's biosurfactant platform. For decades, the production of surfactants for an array of application areas such as agrochemicals, photo chemicals, oil field...

2014-01-23 16:25:21

ELGIN, Ill., Jan. 23, 2014 /PRNewswire/ -- Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014. This patent, currently assigned to 3D Systems, Inc., was revoked at the European level, thus allowing for increased development of materials in this field. (Logo:...

2013-11-19 00:22:33

Independent Committee Unanimously Recommends Transaction TORONTO, Nov. 19, 2013 /PRNewswire/ - Patheon Inc. (TSX:PTI) ("Patheon") today announced that it has entered into an arrangement agreement (the "Arrangement Agreement") with JLL/Delta Patheon Holdings, L.P., a limited partnership ("Newco") under which Patheon would be taken private pursuant to a court-approved plan of arrangement (the "Arrangement") under the Canada Business Corporations Act. Newco is sponsored by an entity...

2013-11-19 00:22:18

Global CDMO company combines DSM Pharmaceutical Products and Patheon NEW YORK and HEERLEN, Netherlands, Nov. 19, 2013 /PRNewswire/ -- JLL Partners ("JLL"), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated sales of around USD 2 billion. It will...

2013-11-12 23:24:43

Reportbuyer.com just published a new market research report: Pharma Contract Manufacturing: World Market Outlook 2013-2023. London (PRWEB) November 12, 2013 Report Details Contracted drug production - discover trends and segments with highest revenue potential Where's outsourced pharma manufacturing heading? Visiongain's updated report predicts that industry's revenues from 2013. There you find potentials for sales growth, also understanding trends, technologies for drugs,...

2013-10-29 20:22:45

PARSIPPANY, N.J., Oct. 29, 2013 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), today officially opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. This world-class operation in the Asia-Pacific...

2013-10-24 04:21:25

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE Euronext: DSM KON), announced today that it has signed a manufacturing agreement for commercial supply with Sanquin Blood Supply Foundation, The Netherlands. PARSIPPANY, N.J., Oct. 24, 2013 /PRNewswire/ -- The agreement covers the commercial manufacture of a monoclonal antibody used for the recovery and purification of coagulation factor IX from human blood. Factor IX is a protein...

2013-10-21 08:23:25

IRVINE, Calif., Oct. 21, 2013 /PRNewswire/ -- ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM (NYSE Euronext Amsterdam: DSM), the global life sciences and material sciences company....

2013-08-21 12:23:37

DSM Nutritional Products and Pop Warner Little Scholars team up to build awareness on importance of nutrition for healthy, active kids COLUMBIA, Md., Aug. 21, 2013 /PRNewswire/ -- Participation in team sports helps young people gain fundamental skills and values useful for the rest of their lives. Now, thanks to a new "Eat Smart, Play Safe" campaign formed by DSM Nutritional Products with Pop Warner Little Scholars, kids in youth sports programs and parents have the opportunity and...